top of page
ultermohlen 1967
ultermohlen 1995
ultermohlen 1997
ultermohlen 1998
ultermohlen 1999
ultermohlen 2000

NEWS on new drug therapies

 

DONANEMAB and LECANEMAB are drugs developed for the treatment of Alzheimer’s disease both targeting the amyloid beta protein which forms plaques in the brain – a hallmark of Alzheimer’s pathology.  Both drugs have been subject of clinical trials with the recent BBC Panorama programme providing a review of the recent results. 
 

Click  here  for our assessment of the benefits and risks of both drugs drawn from data currently available.

The descent into Alzheimer's.

A series of self-portraits 1967 to 2000

by the american artist Walter Ultermolten. (c) with permission.

The Alzheimer's Research Charity is a UK-based charity, registered with the Charity Commission no 1077279.  .

 

Our Mission: to support basic and applied research into the understanding and treatment of Alzheimer's disease.


Our Campaign is guided exclusively by supporting the best scientists and best academic science in Wales, the UK and throughout Europe,

 

The Campaign also supports academic meetings to encourage scientific exchange and collaboration between the leading research centres and teams in Wales, the UK and throughout Europe.

 

Contact us to give your support or to seek advice on our funding streams.

CONTACT US

Dr Sarah-Jane Richards

Alzheimer's Research Charity Europe International office

109 Route de l'Echailler

24160 Preyssac d'Excideuil

FRANCE

Tel: +44 (0) 7584 374153

Email : sarahjane.richards@alzheimersresearch.charity

bottom of page